Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Glucose Sensor Accuracy After Subcutaneous Glucagon Injections Near to Sensor Site

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Dual-hormone artificial pancreas in person with type 1 diabetes

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  3. The artificial pancreas for glucose homeostasis in people with type 1 diabetes

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  4. Low carbohydrate diet elevates blood sphingomyelin in people with type 1 diabetes

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  • Tadej Battelino
  • Thomas Danne
  • Richard M Bergenstal
  • Stephanie A Amiel
  • Roy Beck
  • Torben Biester
  • Emanuele Bosi
  • Bruce A Buckingham
  • William T Cefalu
  • Kelly L Close
  • Claudio Cobelli
  • Eyal Dassau
  • J Hans DeVries
  • Kim C Donaghue
  • Klemen Dovc
  • Francis J Doyle
  • Satish Garg
  • George Grunberger
  • Simon Heller
  • Lutz Heinemann
  • Irl B Hirsch
  • Roman Hovorka
  • Weiping Jia
  • Olga Kordonouri
  • Boris Kovatchev
  • Aaron Kowalski
  • Lori Laffel
  • Brian Levine
  • Alexander Mayorov
  • Chantal Mathieu
  • Helen R Murphy
  • Revital Nimri
  • Kirsten Nørgaard
  • Christopher G Parkin
  • Eric Renard
  • David Rodbard
  • Banshi Saboo
  • Desmond Schatz
  • Keaton Stoner
  • Tatsuiko Urakami
  • Stuart A Weinzimer
  • Moshe Phillip
Vis graf over relationer

Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring (CGM). However, successful utilization of CGM technology in routine clinical practice remains relatively low. This may be due in part to the lack of clear and agreed-upon glycemic targets that both diabetes teams and people with diabetes can work toward. Although unified recommendations for use of key CGM metrics have been established in three separate peer-reviewed articles, formal adoption by diabetes professional organizations and guidance in the practical application of these metrics in clinical practice have been lacking. In February 2019, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address this issue. This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.

OriginalsprogEngelsk
TidsskriftDiabetes Care
Vol/bind42
Udgave nummer8
Sider (fra-til)1593-1603
Antal sider11
ISSN1935-5548
DOI
StatusUdgivet - aug. 2019

Bibliografisk note

© 2019 by the American Diabetes Association.

ID: 58506087